Skip to content
Home/Companies/Biotech/Algeta ASA

Algeta ASA

Biotech·Norway·Exited 2014·Held 9yr
Entry
2005
Hold
9yr
Exit
2014

Who owns Algeta ASA?

Algeta ASA is a Norwegian Biotech company, now owned by Bayer, which acquired it in 2014 from HealthCap.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
HealthCap
Investor
HealthCap
HealthCap V · 2005 · VC

Key facts

HQNorway
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
Bayer
Exit Year
2014

More from HealthCap V

Other portfolio companies in the same fund.

CoreValve SA
Exited 2009
MedTechUS· 2007
to Medtronic
Nexstim Oy
Exited 2014
MedTechFI· 2007
Bonesupport AB
Exited 2017
MedTechSweden· 2006
Alba Therapeutics Corp
Active
BiotechUS· 2005
Cerenis Therapeutics Holding SA
Exited 2015
BiotechFrance· 2005
Jerini AG
Exited 2008
BiotechGermany· 2005
to Shire

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Algeta ASA?

Algeta ASA is now owned by Bayer, which acquired it in 2014 from HealthCap.

When did Bayer acquire Algeta ASA?

Bayer acquired Algeta ASA in 2014, buying from HealthCap.

Who did Algeta ASA sell to?

HealthCap sold Algeta ASA to Bayer in 2014 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue